OpenLB
Open Library of Bioscience
Advanced Search
Clinical case reports
Apr, 2025;13 (4): e70351.

Conservative Management of Thrombotic Microangiopathy in a Renal Transplant Recipient: The Importance of Early Recognition.

Ahmad S Matarneh, Sundus Sardar, Abdel-Rauof Akkari, Pankhuri Mohan, Naman Trivedi, Gurwant Kaur, Nasrollah Ghahramani
Author Information
  1. Ahmad S Matarneh: Department of Nephrology Pennsylvania State Milton S Hershey Medical Center Hershey Pennsylvania USA. ORCID
  2. Sundus Sardar: Department of Nephrology Pennsylvania State Milton S Hershey Medical Center Hershey Pennsylvania USA. ORCID
  3. Abdel-Rauof Akkari: Department of Nephrology Pennsylvania State Milton S Hershey Medical Center Hershey Pennsylvania USA.
  4. Pankhuri Mohan: Department of Medicine-Pediatrics Pennsylvania State Milton S Hershey Medical Center Hershey Pennsylvania USA.
  5. Naman Trivedi: Department of Nephrology Pennsylvania State Milton S Hershey Medical Center Hershey Pennsylvania USA.
  6. Gurwant Kaur: Department of Nephrology Pennsylvania State Milton S Hershey Medical Center Hershey Pennsylvania USA. ORCID
  7. Nasrollah Ghahramani: Department of Nephrology Pennsylvania State Milton S Hershey Medical Center Hershey Pennsylvania USA.
PMID: 40151310 DOI: 10.1002/ccr3.70351

Abstract

Thrombotic microangiopathy (TMA) is a rare but severe complication in renal transplant recipients, often linked to tacrolimus. Early recognition and intervention, such as stopping the drug, are crucial to preventing graft loss. This case highlights the importance of prompt diagnosis and vigilance for subtle signs to ensure effective management.

Keywords

ESRD TMA allograft dysfunction calcinurin inhibitors immunosuppressed renal transplant

References

  1. Cureus. 2023 Nov 24;15(11):e49351 [PMID: 38146570]
  2. Arthritis Rheumatol. 2024 Feb;76(2):153-165 [PMID: 37610060]
  3. World J Transplant. 2024 Mar 18;14(1):90277 [PMID: 38576763]
  4. Transplantation. 2023 Nov 1;107(11):2329-2340 [PMID: 36944606]
  5. Annu Rev Pathol. 2008;3:189-220 [PMID: 18039144]
  6. Expert Rev Hematol. 2023 Mar;16(3):191-203 [PMID: 36588482]
  7. Am J Transplant. 2024 Jul;24(7):1205-1217 [PMID: 38320731]
  8. Blood. 2020 Mar 26;135(13):1049-1057 [PMID: 31932840]
  9. Front Pharmacol. 2023 Jan 09;13:1088031 [PMID: 36699080]
  10. BMC Nephrol. 2023 Sep 20;24(1):278 [PMID: 37730583]
  11. Am J Kidney Dis. 2023 May;81(5):591-605 [PMID: 36509342]
  12. J Immunol. 2013 Dec 15;191(12):5785-91 [PMID: 24319282]
  13. J Am Soc Nephrol. 2017 Aug;28(8):2290-2301 [PMID: 28630231]
  14. Am J Transplant. 2024 Sep;24(9):1708-1709 [PMID: 38677652]
Journal Article

Word Cloud

Created with Highcharts 10.0.0ThromboticTMArenaltransplantEarlymicroangiopathyrareseverecomplicationrecipientsoftenlinkedtacrolimusrecognitioninterventionstoppingdrugcrucialpreventinggraftlosscasehighlightsimportancepromptdiagnosisvigilancesubtlesignsensureeffectivemanagementConservativeManagementMicroangiopathyRenalTransplantRecipient:ImportanceRecognitionESRDallograftdysfunctioncalcinurininhibitorsimmunosuppressed

Similar Articles

Cited By